The digital biomarkers market size was valued at US$2.3 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 25.7% during 2022-2027. The digital biomakers in healthcare market report provides an executive-level overview of the digital biomakers market worldwide today, with detailed forecasts of key indicators up to 2027.
This market intelligence report offers a thorough, forward-looking analysis of the global digital biomarkers market, and key product and platform stack in a concise format to help executives build proactive and profitable growth strategies.
The market is driven by the aging population, increasing investment and funding to develop digital biomarkers, and an increase in M&A and partnership to boost the adoption of biomarkers.
This market intelligence report offers a thorough, forward-looking analysis of the global digital biomarkers market, and key product and platform stack in a concise format to help executives build proactive and profitable growth strategies.
The market is driven by the aging population, increasing investment and funding to develop digital biomarkers, and an increase in M&A and partnership to boost the adoption of biomarkers.
Scope
- Overview of digital biomarkers including industry trends, funding & deals, regulatory details, and product & company profile
- digital biomarkers market outlook: analysis as well as historical figures and forecasts of revenue opportunities from the product type, type, therapeutic area, end-user, and geographic segments
- Digital biomarkers market outlook: analysis as well as forecasts of revenue opportunities from the key end-user segments
- Digital biomarkers in healthcare market outlook: analysis as well as forecasts of revenue opportunities from the type segment
- Digital biomarkers in healthcare market outlook: analysis as well as forecasts of revenue opportunities from the product type segment. Digital biomarkers in healthcare market outlook: analysis as well as forecasts of revenue opportunities from the end-user segment
- The competitive landscape: an examination of the positioning of leading players in digital biomarkers market
Reasons to Buy
- This market intelligence report offers a thorough, forward-looking analysis of the global digital biomarkers market and key opportunities in a concise format to help executives build proactive and profitable growth strategies
- Accompanying the publisher's Forecast products, the report examines the assumptions and drivers behind ongoing and upcoming trends in digital biomarkers markets
- The report also highlights key type, product type, end-user, therapeutic area, and technology segments
- With different charts and tables, the report is designed for an executive-level audience, boasting presentation quality
- The report provides an easily digestible market assessment for decision-makers built around in-depth information gathered from market players, which enables executives to quickly get up to speed with the current and emerging trends in digital biomarkers market
Table of Contents
CHAPTER 01 Executive Summary
CHAPTER 02 Market Landscape
CHAPTER 03 Digital Biomarkers Value Chain
CHAPTER 04 Digital Biomarkers Industry Analysis
CHAPTER 05 Global Digital Biomarkers Revenue Opportunity
CHAPTER 06 Regulatory Overview
CHAPTER 07 Digital Biomarkers Type Outlook
CHAPTER 08 Digital Biomarkers in Product Type Outlook
CHAPTER 09 Digital Biomarkers in Therapeutic Area Outlook
CHAPTER 010 Digital Biomarkers End-User Outlook
CHAPTER 011 Digital Biomarkers Regional Outlook
CHAPTER 012 Trends, Drivers, and Challenges
CHAPTER 014 Digital Biomarkers Vendor Snapshot
CHAPTER 015 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ActiGraph LLC
- AliveCor Inc.
- Biogen Inc.
- Akili Interactive Labs Inc.
- Emblic Corp.
- Fitbit
- Happify Health
- Huma
- Ixico Plc